Filing Flows › Collegium Pharmaceutical (COLL) › Operating margin
Collegium Pharmaceutical (COLL) operating margin by quarter
Collegium Pharmaceutical's operating margin was 13.3% in Q3 2026 (third quarter 2026), -2.7 pts from Q1 2026. Over the last 6 quarters it ranged from 12.2% (Q1 2025) to 29.7% (Q3 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 13.3% | -2.7 pts | -16.4 pts |
| Q1 2026 | 16.0% | -13.6 pts | +3.8 pts |
| Q4 2025 | 29.6% | -0.1 pts | — |
| Q3 2025 | 29.7% | +11.0 pts | — |
| Q2 2025 | 18.7% | +6.5 pts | — |
| Q1 2025 | 12.2% | — | — |
Q3 2026 at a glance
Collegium Pharmaceutical, Q3 2026: revenue $216M (+3% year over year), operating margin 13.3%, net earnings $21.8M, operating cash flow $86.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Collegium Pharmaceutical's operating margin?
Collegium Pharmaceutical's operating margin was 13.3% in Q3 2026 (third quarter 2026), -2.7 pts from Q1 2026.
How has Collegium Pharmaceutical's operating margin changed?
Over the last 6 quarters it ranged from 12.2% (Q1 2025) to 29.7% (Q3 2025).
Q3 2026 results → · How Collegium Pharmaceutical makes money →